Rila Therapeutics
Biotechnology Research • 
South San Francisco, California, United States • 1-10 Employees
Company overview
| Headquarters | 280 Utah Avenue, Suite, suite 250, South San Francisco, CA 94080, US |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Key Contact at Rila Therapeutics
Robert Drakas
Co-founding CEO and Director
About Rila Therapeutics
Rila Therapeutics is a biotechnology company developing novel therapeutics to treat fibrotic diseases. Rila was founded by John He, chief of nephrology at Icahn Mount Sinai and key opinion leader at one of the largest medical centers in the U.S., and ShangPharma Innovation. He, in addition to his position at Icahn Mount Sinai, is a professor of medicine and pharmacological sciences whose academic work has shed light on multiple features of kidney disease pathogenesis, leading to the elucidation of complex signaling networks in kidney cells by using systems biology approach and transgenic mouse models, and revealing the novel mechanisms of kidney fibrosis.
Rila Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Rila Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Rila Therapeutics has never raised funding before.
Rila Therapeutics Tech Stack
Discover the technologies and tools that power Rila Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript libraries
Hosting
Miscellaneous
Programming languages
Blogs
UI frameworks
Databases
Hosting
Font scripts
SwedenFrequently asked questions
4.8
40,000 users
